Skip to main content

Is greed holding back a drug that could treat COVID-19 patients?

By refusing to test a promising drug for COVID-19, Gilead Sciences is accused of putting profit ahead of the public health.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.